三生制药于2026年6月1日披露了截至2026年5月31日的证券变动月报表。公告显示，公司法定股本及已发行股份结构在报告期内出现小幅变动。
根据公告信息，截至5月末，公司法定股本依旧为50,000,000,000股，面值每股0.00001美元，对应法定/注册股本总额500,000美元，与上月底持平。
本月普通股的已发行股份数量由原先的2,538,039,412股增至2,538,084,412股，新增45,000股，主要源自员工股份期权行使。公告显示，行使期权所获款项合计342,900港元。公司当月并未发生回购或注销股份及库藏股变化事宜。
公告称，公司已符合香港联交所适用的公众持股量要求。截至2026年5月31日，三生制药已发行股份总数为2,538,084,412股。该月报表由公司秘书记黎少娟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.